NCT03946566

Brief Summary

Electronic health records of stroke convalescent patients will be selected from the third affiliated hospital of Zhejiang Chinese Medical University from January 2012 to December 2019. Relevant clinical data will be extracted according to case data, and model-based decision tree analysis will be conducted to establish and evaluate the clinical prediction Model.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 7, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 10, 2019

Completed
22 days until next milestone

Study Start

First participant enrolled

June 1, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2020

Completed
Last Updated

May 14, 2019

Status Verified

May 1, 2019

Enrollment Period

7 months

First QC Date

May 7, 2019

Last Update Submit

May 13, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Clinical Neurological Functional Impairment Assessment for Stroke Patients

    To evaluate the consciousness, muscle power, dysarthria, sensory disturbancen and ataxia of stroke patients on the first day, the seventh day, the fifteenth day, the first month and the sixth month after admission (or the last time of discharge).The total score is 0-29 points. The lower the score, the less the neurological defect. The efficacy will be assessed as an improvement in the neurological functional impairment score (eg, score improvement = score at admission - score at discharge), and treatment was effective when the score was reduced by more than 18%.

    Change from neurological functional impairment score at 6 months(or the last discharge time ,which less than 6 months)

Study Arms (2)

Acupuncture group

Using acupuncture, electric acupuncture, moxibustion and acupoint injection treatment.

Procedure: Acupuncture

Basic treatment group

Use basic treatments, such as western medicine.

Procedure: Acupuncture

Interventions

AcupuncturePROCEDURE

Using acupuncture, electric acupuncture, moxibustion and acupoint injection treatment.

Acupuncture groupBasic treatment group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study population will be stroke convalescent patients from The Third Affiliated Hospital of Zhejiang Chinese Medical University from January 2012 to December 2019.

You may qualify if:

  • Clinical diagnosis of stroke
  • The incidence is between 30 days and 180 days
  • Age ≥ 18 years old
  • The first onset

You may not qualify if:

  • Subarachnoid hemorrhage
  • transient ischemic attack
  • other intracranial lesions
  • Non-atherosclerotic thrombotic cerebral infarction
  • Surgery, trauma, congenital disability leading to limb dysfunction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Third Affiliated Hospital of Zhejiang Chinese Medical University

Hangzhou, Zhejiang, 310000, China

RECRUITING

MeSH Terms

Conditions

Stroke

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Ruijie Ma, Doctor

    The Third Affiliated hospital of Zhejiang Chinese Medical University

    STUDY DIRECTOR

Central Study Contacts

Huiting Yang, Bachelor

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
physician

Study Record Dates

First Submitted

May 7, 2019

First Posted

May 10, 2019

Study Start

June 1, 2019

Primary Completion

December 31, 2019

Study Completion

March 31, 2020

Last Updated

May 14, 2019

Record last verified: 2019-05

Locations